Trial | NCT02242513  Report issue

Title

Ultrasound-guided Pulsed Radiofrequency for Plantar Fasciitis
Ultrasound-guided Pulsed Radiofrequency Stimulation of the Tibial Nerve for Plantar Fasciitis

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    lidocaine ...

  • Study Participants

    36
Although there are many conservative method for plantar fasciitis, patients might spend 2 years to achieve resolution. Recent study have shown that pulsed radiofrequency (PRF) lesioning of peripheral nerve can alleviate kinds of pain condition. However there are no studies of PRF lesioning of the tibial nerve in patients with plantar fascilitis by using ultrasound-guided (UG) techniques.
Patients with unilateral plantar Fasciitis will be enrolled and randomized into intervention and control group. One dose of sono-guided PRF is applied in the intervention group and xylocaine in control group. Outcome measurements included visual analog scale (VAS)、foot health status questionnaire and the thickness of plantar fascile measured by musculoskeletal ultrasonography at different follow-up frame (4th week, 2nd month, 3rd month after treatment).
Study Started
Apr 30
2014
Primary Completion
Jul 31
2016
Study Completion
Jul 31
2016
Last Update
Dec 01
2016
Estimate

Device Pulsed radiofrequency (PRF)

Pulsed radiofrequency (PRF) treatment, a relative novel pain intervention at recent decade, was found to be able to alleviate pain by delivering an electrical field and heat bursts at a temperature less than 42°C to neural tissue in the absence of neural injury.

  • Other names: Neurotherm NT1000, Neurotherm Inc., USA

Drug Xylocaine

pulsed mode radiofrequency Active Comparator

Pulsed radiofrequency (PRF) treatment, a relative novel pain intervention at recent decade, was found to be able to alleviate pain by delivering an electrical field and heat bursts at a temperature less than 42°C to neural tissue in the absence of neural injury. One dose of PRF was given in tibial nerve behine the medial ankle in intervention group.

Xylocaine Placebo Comparator

2 c.c xylocaine was given in tibial nerve behind the medial ankle in control group.

Criteria 

Inclusion Criteria:

Heel pain more than 3 months
Age more than 20 year-old
The increased thickness of plantar fascile (>4mm) measured by sonography
Must be conscious
Not receive steroid or other injection in plantar fascile in past 6 months

Exclusion Criteria:

Cancer of any site
Coagulopathy
Pregnancy
Inflammation status
No Results Posted